Dublin, Jan. 06, 2026 (GLOBE NEWSWIRE) -- The "Shanghai Kehua Bio-engineering Co Ltd (002022) - Product Pipeline Analysis, 2025 Update" has been added to ResearchAndMarkets.com's offering.
Shanghai Kehua Bio-engineering Co Ltd (KHB) is a leading developer, manufacturer, and marketer of in vitro diagnostic (IVD) devices and associated products. KHB specializes in diagnostic reagents and instruments across key areas such as biochemical diagnostics, immunodiagnostics, molecular diagnostics, and point-of-care testing. These products are vital for clinical diagnosis, treatment, blood screening, public health initiatives, food safety, and scientific research.
Highlighting KHB's commitment to innovation, the company has formed strategic partnerships with prominent international firms to boost its research and development (R&D) capabilities. KHB operates R&D and manufacturing facilities in Italy, Shenzhen, Xi'an, and Suzhou, with sales support located in major Chinese cities. Its products are distributed domestically and internationally, cementing KHB's global market presence. The company is headquartered in Shanghai, China.
This report serves as a comprehensive source for data, analysis, and actionable intelligence concerning KHB's portfolio and pipeline products. It offers key insights into the company's major offerings and brand strength. The report is designed to enhance decision-making capabilities and assist in crafting effective counter-strategies for competitive advantage.
Report Scope:
- Providing an in-depth company profile, the report includes business descriptions, key company data, major products and services, primary competitors, key employees, and recent developments.
- The analysis covers all pipeline products currently in development by KHB.
- Detailed pipeline analysis by equipment type, indication, development stage, and trial status.
- In-depth insights on each pipeline product, including pipeline territory, development stage, device class, regulatory path, indications, applications, and estimated launch dates.
- Ongoing clinical trials data, including trial names, objectives, sponsors, designs, statuses, phases, and projected start and end dates.
Reasons to Buy:
- Formulate business strategies by understanding trends and developments in the medical devices pipeline and technology landscape.
- Develop product development, marketing, and sales strategies by analyzing competitor portfolios.
- Forge effective Research & Development strategies.
- Craft market-entry and expansion strategies.
- Capitalize on in-licensing and out-licensing opportunities by identifying high-return products.
- Strategically plan mergers and acquisitions by identifying key players in the most promising pipelines.
- Identify emerging players with strong product portfolios and develop effective counter-strategies for competitive advantage.
- Analyze competition strategies by reviewing clinical trials, development stages, and anticipated product launches.
- Recognize, understand, and capitalize on forthcoming high-value products to be added to competitor portfolios.
Key Topics Covered:
Shanghai Kehua Bio-engineering Co Ltd Company Overview
Business Description
Shanghai Kehua Bio-engineering Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Shanghai Kehua Bio-engineering Co Ltd Pipeline Products by Development Stage
- Shanghai Kehua Bio-engineering Co Ltd Pipeline Products Overview
Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - Folate
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - Intact PTH
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - PIVKA II
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - Serum rT3
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - TRAB
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - Vitamin B12
- Polaris i2400 Automatic Chemiluminescence Immunassay Analyzer - Vitamin D
Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer
- Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer - 25 (OH) VD
- Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer - Folate
- Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer - Intact PTH
- Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer - Total IgE
- Polaris V150 Automatic Chemiluminescence Immunoassay Analyzer - Vitamin B12
Third Generation HIV Rapid Detection Test
Shanghai Kehua Bio-engineering Co Ltd - Key Competitors
Shanghai Kehua Bio-engineering Co Ltd - Key Employees
- Shanghai Kehua Bio-engineering Co Ltd - Key Employee Biographies
Shanghai Kehua Bio-engineering Co Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
For more information about this company profile visit https://www.researchandmarkets.com/r/z7062d
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
